ICPT


These 3 Biotech Stocks Could More Than Double in 2020, Says Wedbush

Which stocks can go from zero to one hundred overnight? Wall Street pros point to biotechs.

Don’t Say Bye Bye to Intercept (ICPT) Stock, Say Buy Buy

With Intercept (ICPT) preparing to release Phase 3 results from its REGENERATE study in Non-Alcoholic Steatohepatitis (NASH) patients, Gilead (GILD) announced yesterday that its top late-stage NASH drug …

Company Update (NASDAQ:ICPT): Intercept Pharmaceuticals Inc Announces 3Q:17 Financial Results and Provides Business Update

Intercept Pharmaceuticals Inc (NASDAQ:ICPT) reported financial results for the three months ended September 30, 2017, and provided other general business updates. “We are …

Intercept Pharmaceuticals Inc (ICPT) Presents Additional Results From Phase 2 Study of OCA for the Treatment of Patients with PSC

Intercept Pharmaceuticals Inc (NASDAQ:ICPT) announced additional results of the phase 2 clinical trial with obeticholic acid (OCA), a potent farnesoid X receptor agonist …

Marshall Wace Pulled Back Holding in Intercept Pharmaceuticals Inc (ICPT), Optimistic About Valeant Pharmaceuticals Intl Inc (VRX) and Exelixis, Inc. (EXEL)

A first glance at this hedge fund’s strategic Q2 moves in biotech sector.

A Glimpse Into the Biotech Sector: Intercept Pharmaceuticals Inc (ICPT), IntelliPharmaCeutics Intl Inc (USA) (IPCI)

Intercept Pharmaceuticals Inc (NASDAQ:ICPT) management hosted a conference call this morning to address Ocaliva safety concerns. As a reminder, company issued a Healthcare …

Intercept Pharmaceuticals Inc (ICPT) Comments on Ocaliva Safety and Dosing

Intercept Pharmaceuticals Inc (NASDAQ:ICPT) provided comment on the Ocaliva (obeticholic acid or OCA) Dear Healthcare Provider (DHCP) letter issued on September 12, 2017, …

Top Analyst Cuts Price Target For Intercept Pharmaceuticals Inc (ICPT) By 50%; Here’s Why

Intercept Sank 40% in September following Dear Doctor and FDA warning letters; Ritu Baral weighs in.

Intercept Pharmaceuticals Inc (ICPT) Investors Run for the Hills; Here’s Why

Shares of drug maker Intercept Pharmaceuticals Inc (NASDAQ:ICPT) are in a freefall today. Why?

Top Analyst Shines Light on Intercept Pharmaceuticals Inc’s (ICPT) Dear Health Care Provider Letter

Dear doctor: My shares just fell 15%.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts